,,ii #aaith ,,congress #b;d ,session ,s4 #edhh ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,september #bc1 #bjbf,mr4 ,van ,hollen 7for himself1 ,mr4 ,booker1 and ,ms4 ,klobuchar7 introduced the following bill2 which was read twice and referred to the ,committee on ,health1 ,education1 ,labor1 and ,pensions ,a ,,bill ,to establish a program to address sickle cell disease and other heritable hemoglobinopathies4 #a4 ,short title ,this ,act may be cited as the ,sickle ,cell ,disease ,treatment ,centers ,act of #bjbf4 #b4 ,establishment of sickle cell disease and other heritable hemoglobinopathies treatment centers ,subpart ,i of part ,d of title ,,iii of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #bed;b et seq47 is amended by inserting after section #ccj,p 7#db ,u4,s4,c4 #bed;c-#bb7 the following3 #ccj,q4 ,sickle cell disease and other heritable hemoglobinopathies treatment centers 7a7 ,definitions ,in this section3 7#a7 ,community-based organization ,the term community-based organization means a community-based nonprofit organization4 7#b7 ,hub-and-spoke network ,the term hub-and-spoke network means a system for delivery of health care services-- 7,a7 in which a medical hub identifies and manages a medical spoke or network of spokes1 to provide comprehensive sickle cell disease care2 7,b7 in which such entities serving as spokes-- 7i7 may provide sickle cell disease care services2 and 7ii7 may increase services over time to meet the definition of medical hubs and connect with new spokes2 and 7,c7 in which the medical hub-and-spoke has a partnership with one or more community-based organizations to extend services and outreach to the sickle cell disease community4 7#c7 ,medical hub ,the term medical hub means a hospital1 clinic1 or university health center that-- 7,a7 provides comprehensive sickle cell disease treatment1 which may include medical and surgical treatment1 such as provision of stem cell transplants and cell and gene therapies1 an outpatient treatment clinic led by a board-certified hematologist1 infusion capability1 telehealth capability1 genetic counseling1 access to home care1 and a pharmacy2 7,b7 has experience serving individuals living with sickle cell disease or other hemoglobinopathies2 7,c7 follows consensus-based clinical practice guidelines2 and 7,d7 may be a grantee or coordinate with grantees of the ,sickle ,cell ,disease ,treatment ,demonstration ,program under section #aajf7;b74 7#d7 ,spoke ,the term spoke means an entity-- 7,a7 that provides health care services1 including-- 7i7 a ,federally-qualified health center1 as defined in section #aije7l77#b77;,b7 of the ,social ,security ,act2 7ii7 a hospital1 clinic1 or university health center that provides clinical care and has telehealth capability2 7iii7 a primary care provider2 7iv7 an outpatient treatment clinic2 7v7 an infusion center2 or 7vi7 other health care providers2 7,b7 that has at least #a collaborative agreement with a medical hub and one or more community-based organization2 and 7,c7 that incorporates a community health worker into the care team4 7b7 ,program established ,the ,secretary shall award grants to eligible entities to establish treatment centers using a hub-and-spoke framework 7referred to in this section as ,sickle ,cell ,disease ,treatment ,centers71 for the purposes of-- 7#a7 promoting access to coordinated1 lifelong health care for all patients with sickle cell disease2 7#b7 providing support to establish integrated health care teams for patients with sickle cell disease over a patient's lifetime2 7#c7 improving the health and well-being of children1 youth1 and adults with sickle cell disease2 7#d7 improving the pediatric-to-adult health care transition2 7#e7 collecting and contributing clinical data from ,states participating in the ,sickle ,cell ,data ,collection program of the ,centers for ,disease ,control and ,prevention1 including the collection of health outcomes and associated complications reported pursuant to such program2 7#f7 ensuring that reporting with respect to sickle cell disease includes reporting on all patients with sickle cell disease1 including migrating and foreign-born patients2 and 7#g7 conducting significant public health awareness and education activities with respect to sickle cell disease and sickle cell trait4 7c7 ,eligible entity ,the term eligible entity means any entity that is comprised of-- 7#a7 a hub-and-spoke network that includes-- 7,a7 a medical hub that is a hospital1 clinic1 or university health center2 and 7,b7 at least #a spoke working in partnership with the medical hub2 and 7#b7 at least #a community-based nonprofit organization working in a partnership with the hub-and-spoke network4 7d7 ,use of funds by eligible entities ,an eligible entity shall use grant funds received under this section as follows3 7#a7 ,medical hub ,the medical hub of the eligible entity shall carry out the following3 7,a7 ,operating and administrating costs of operating a hub-and-spoke framework4 7,b7 ,complying with consensus-based sickle cell disease treatment guidelines1 as identified by the ,secretary4 7,c7 ,educating health care providers on sickle cell disease treatment standards and protocols4 7,d7 ,providing integrated care management1 which may include-- 7i7 primary care2 7ii7 specialty care2 7iii7 pain management2 7iv7 mental health services2 7v7 genetic counseling services2 and 7vi7 other services4 7,e7 ,coordinating specialty care services1 whether provided at the medical hub or spoke4 7,f7 ,coordinating reproductive health and family planning services for patients with sickle cell disease1 trait1 or other hemoglobinopathies4 7,g7 ,providing a dedicated sickle cell expert at the medical hub to assist in overseeing care of sickle cell disease patients at spokes and to advise the community-based organization4 7,h7 ,educating health care providers on social determinants of health and implicit bias that may affect quality of care and life for patients with sickle cell disease1 trait1 or other hemoglobinopathies4 7,i7 ,providing telehealth appointments to patients when appropriate and facilitating access to telehealth services for sickle cell disease patients to the extent feasible4 7,j7 ,implementing pediatric-to-adult health care transition programs for purposes of ensuring coordinated patient graduation from pediatric to adult providers for all patients4 7,k7 ,providing social work services or community health worker services in coordination with one or more community-based organizations4 7,l7 ,collecting and distributing data as required by the ,national ,sickle ,cell ,disease ,coordinating ,center established under subsection 7f7 or otherwise required by the ,secretary4 7,m7 ,engaging in quality improvement with respect to such standards of care for health and quality of life outcomes among sickle cell disease patients as the ,secretary may require4 7#b7 ,community-based organization ,the community-based organization of the eligible entity shall provide or coordinate services to patients and families1 which may include the following3 7,a7 ,providing education and outreach to individuals at-risk for sickle cell trait1 individuals with sickle cell trait1 sickle cell disease patients1 caregivers1 and health care providers4 7,b7 ,providing support in addressing social determinants of health1 such as food insecurity1 housing insecurity1 and access to education and transportation4 7,c7 ,providing social work services or community health worker services in coordination with a medical hub or spoke4 7,d7 ,testing or coordinating testing for individuals at-risk for sickle cell trait and individuals with sickle cell trait that increase the likelihood of having a child with sickle cell disease1 including through coordination with a genetic counselor4 7,e7 ,engaging in quality improvement with respect to standards of care or health and quality of life outcomes among sickle cell disease patients1 as identified by the ,secretary4 7#c7 ,spoke ,the spokes of the eligible entity shall provide or coordinate each of the following services3 7,a7 ,collaborating with a medical hub to coordinate and support care for sickle cell disease patients4 7,b7 ,providing standards of care as developed in coordination with the medical hub4 7,c7 ,providing primary care services1 genetic counseling1 or specialty care4 7,d7 ,providing telehealth appointments1 as appropriate4 7,e7 ,providing medical or surgical treatment4 7,f7 ,implementing individual care plans4 7,g7 ,providing social work services or community health worker services in coordination with one or more community-based organizations4 7,h7 ,collecting and distributing data as required by the ,national ,sickle ,cell ,disease ,coordinating ,center established under subsection 7f74 7#d7 ,additional uses of funds ,in addition to the uses of funds described in paragraphs 7#a71 7#b71 and 7#c71 an eligible entity selected to receive a grant under this section may use funds received through the grant-- 7,a7 to identify and secure resources for ensuring reimbursement under1 for the ,state involved1 the ,state plan under title ,,xix of the ,social ,security ,act 7or a waiver of such plan71 ,state child health plan under title ,,xxi of such ,act 7or a waiver of such plan71 and other health programs for the prevention and treatment of sickle cell disease1 including by working with community-based sickle cell disease organizations and other nonprofit entities2 7,b7 to assist sickle cell disease patients with accessing appropriate health insurance1 including-- 7i7 through the payment of insurance premiums and cost-sharing amounts1 to the extent otherwise permitted under ,state and ,federal law2 7ii7 by working with community-based sickle cell disease organizations and other nonprofit entities2 and 7iii7 by helping sickle cell disease patients know their rights with insurance programs2 7,c7 to facilitate access to telehealth services for sickle cell disease patients and individuals with sickle cell trait1 to the extent feasible2 7,d7 to fund evidence-based programs that provide education to health care providers1 teachers and school personnel1 and correctional institutional personnel1 on the care of individuals with sickle cell disease or trait in health care settings and other appropriate settings1 including schools and prisons2 7,e7 to develop a system of social and community supports1 including transportation services or travel reimbursement for sickle cell disease patients who do not have1 but who need access to1 in-person care with the ,sickle ,cell ,disease ,treatment ,centers2 and 7,f7 to facilitate access to sickle cell trait testing and genetic counseling4 7e7 ,application2 selection 7#a7 ,application ,an eligible entity desiring a grant under this section shall submit an application to the ,secretary at such time1 in such manner1 and containing such information as the ,secretary may require1 including a description of how the hub-and-spoke entity and community-based organization will collaborate in carrying out the activities described in subsection 7d74 7#b7 ,geographic distribution ,the ,secretary shall award grants under this section1 to the extent practicable1 to eligible entities1 with a focus on regions where a disproportionate number of patients with sickle cell disease1 individuals with sickle cell trait1 or other heritable hemoglobinopathy patients per capita reside1 and to eligible entities nationwide so that patients can access more comprehensive sickle cell disease treatment services no matter where they reside4 7#c7 ,priorities in making awards ,in awarding grants under this section1 the ,secretary may give priority to eligible entities that-- 7,a7 include at least one historically ,black college or university 7defined as a part ,b institution under section #cbb of the ,higher ,education ,act of #aife7 or minority serving institution 7defined as an eligible institution under section #cga of such ,act7 that has a medical school1 nursing school1 nurse practitioner or physician assistant program1 genetic counseling program1 or school of social work2 7,b7 serve an area with a high prevalence of sickle cell disease2 or 7,c7 serve a rural area4 7f7 ,national sickle cell disease coordinating center 7#a7 ,in general ,the ,secretary shall establish1 or enter a cooperative agreement with an entity to establish1 the ,national ,sickle ,cell ,disease ,coordinating ,center1 which shall coordinate the activities conducted by grantees under this section and carry out the activities described in paragraph 7#b74 7#b7 ,duties ,the ,national ,sickle ,cell ,disease ,coordinating ,center shall carry out each of the following activities3 7,a7 ,advise the ,secretary on the design and implementation of1 and coordinate the infrastructure of1 the ,sickle ,cell ,disease ,treatment ,centers established under subsection 7b71 including with respect to administrative requirements and ensuring that sickle cell health care is available across the ,united ,states4 7,b7 ,develop a national strategy for the practice of equitable care1 coordinated comprehensive quality care1 research and resources for patients and health care providers1 and treatment modality options to improve patient outcomes1 and submit such national strategy to the ,secretary4 7,c7 ,coordinate with ,federal agencies to improve data collection over the lifespan of patients and routinely update a national needs assessment to improve care for individuals impacted by sickle cell disease4 7,d7 ,coordinate with hub-and-spoke networks1 patients1 researchers1 and health care providers to maintain a comprehensive sickle cell research1 treatment1 and national care strategy4 7,e7 ,establish a rotating panel of stakeholders1 including health care providers1 patients1 individuals impacted by sickle cell disease1 allied health professionals1 care coordinators1 social workers1 community health workers1 and sickle cell community-based and advocacy organizations to advise the ,center1 provide up-to-date information and forecasts on status and plans for improving sickle cell care1 treatment1 and access to treatment modalities for individuals and families living with sickle cell disease4 7,f7 ,coordinate and support hub-and-spoke frameworks4 7,g7 ,support improvement in patient and family-centered care1 health outcomes1 and care affordability by improving access to care4 7,h7 ,provide or coordinate technical assistance and support to health care providers1 family members and advocates1 public health professionals1 policymakers1 and patients that want to improve access to quality care1 telemedicine1 family planning1 health care transition1 and family and community engagement4 7,i7 ,inform and educate the public about sickle cell disease1 sickle cell trait1 and options for quality care4 7g7 ,,cdc sickle cell disease data collection program for ,,scd treatment centers ,the ,secretary1 acting through the ,director of the ,centers for ,disease ,control and ,prevention1 in coordination with the ,national ,sickle ,cell ,coordinating ,center established under subsection 7f71 shall carry out the following3 7#a7 ,collecting1 coordinating1 monitoring1 and distributing data1 best practices1 and findings regarding the activities funded under grants made to eligible entities under this section4 7#b7 ,collecting and maintaining up-to-date data on sickle cell disease1 including subtypes as applicable1 and their associated health outcomes and complications1 in consultation with ,states participating in the ,sickle ,cell ,data ,collection of the ,centers for ,disease ,control and ,prevention1 including for the purpose of-- 7,a7 improving national incidence and prevalence data1 including the geographic distribution of affected individuals2 7,b7 identifying health disparities impacting individuals born with sickle cell disease1 including subtypes as applicable1 and other hemoglobinopathies2 7,c7 assessing the utilization of therapies1 comprehensive complication risk screening1 and strategies to prevent complications resulting from sickle cell disease and to increase quality of life2 and 7,d7 evaluating the effects of genetic1 environmental1 behavioral1 and other risk factors that may affect individuals with sickle cell disease4 7#c7 ,developing educational materials1 public awareness campaigns1 or other outreach programs regarding the inheritance pattern1 treatment of1 and prevention of complications from sickle cell disease and prevalence of sickle cell trait1 as well as programs and activities that will enhance the lives of individuals living with sickle cell disease and sickle cell disease trait4 7h7 ,request for information ,not later than #ahj days after the date of enactment of the ,sickle ,cell ,disease ,treatment ,centers ,act of #bjbf1 and in advance of each new grant cycle thereafter1 the ,secretary shall publish in the ,federal ,register a request for information seeking feedback from stakeholders on-- 7#a7 best practices with respect to the establishment and implementation of ,sickle ,cell ,disease ,treatment ,centers2 and 7#b7 any other information that the ,secretary may require4 7i7 ,report to ,congress 7#a7 ,in general ,not later than #c years after the date of the enactment of the ,sickle ,cell ,disease ,treatment ,centers ,act of #bjbf1 and every #e years thereafter1 the ,secretary shall submit to the ,committee on ,health1 ,education1 ,labor1 and ,pensions and the ,committee on ,appropriations of the ,senate and the ,committee on ,energy and ,commerce and the ,committee on ,appropriations of the ,house of ,representatives a report on the impact of the ,sickle ,cell ,disease ,treatment ,centers established under this section on health outcomes for sickle cell disease patients4 7#b7 ,report elements ,the report described in this section shall include-- 7,a7 a summary and description of eligible entities operating a hub-and-spoke system that are receiving grant funds under this section2 7,b7 information about the specific activities supported by grant funds awarded under this section with respect to each eligible entity2 7,c7 the number of sickle cell disease patients served by grant programs funded under this section and demographic information about those patients1 including race1 sex1 gender1 geographic location1 and age2 and 7,d7 information about patient experiences with the hub-and-spoke system and community-based organizations4 7j7 ,supplement1 not supplant ,the activities under this section shall supplement1 not supplant1 otherwise authorized activities of the ,department of ,health and ,human ,services relating to sickle cell disease4 7k7 ,authorization of appropriations 7#a7 ,in general ,to carry out this section1 there are authorized to be appropriated such sums as may be necessary for fiscal year #bjbg and each fiscal year thereafter4 7#b7 ,allocation to activities ,of the amount appropriated under paragraph 7#a7 for a fiscal year-- 7,a7 #gj percent may be awarded to eligible entities for purposes of supporting the activities of hub-and-spoke networks that are a part of such eligible entities2 7,b7 #bj percent may be awarded to eligible entities for purposes of supporting the activities of community-based organizations that are a part of such eligible entities2 7,c7 #e percent may be used for the establishment and maintenance of the ,national ,sickle ,cell ,disease ,coordinating ,center described in subsection 7f72 and 7,d7 #e percent may be used for the activities of the ,sickle ,cell ,data ,collection program of the ,centers for ,disease ,control and ,prevention described in subsection 7g74 4